首页 › 基金 › SALT Holding Corp. › GSK
SALT Holding Corp. 对 GSK 的持仓历史
GSK PLC · 医疗保健
SALT Holding Corp. 在 Q3 2026 的 13F 申报中披露持有 GSK(GSK PLC)235,459 股,市值约 US$11.3M,约占其申报组合的 5.87%,在其申报持仓中市值排名第 5 位。 SALT Holding Corp. 最近 8 个申报季度中有 4 个季度披露了 GSK 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
SALT Holding Corp. 对 GSK 的持仓演变
SALT Holding Corp. 于 Q4 2024 首次披露 GSK 持仓:61,612 股(约 US$2.1M)。 该持仓在 Q2 2026 达到峰值 235,459 股,市值约 US$12.3M。 在 4 次申报中,SALT Holding Corp. 1 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 235,459 股、市值约 US$11.3M。 持仓曾出现大幅变动:Q1 2025 增持约 47% (随后一个季度股价基本持平)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 61.61K | $2.08M | 新进 |
| Q1 2025 | 90.66K | $3.51M | 增持 |
| Q2 2026 | 235.46K | $12.34M | 新进 |
| Q3 2026 | 235.46K | $11.34M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GSK 与 13F 数据
GSK(GSK PLC)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 GSK,申报仓位最大的包括:Dodge & Cox (US$2.53B), DODGE & COX (US$2.08B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GSK 的基金
- Dodge & Cox 48.20M 股 · $2.53B · Q2 2026
- DODGE & COX 43.18M 股 · $2.08B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.19M 股 · $1.21B · Q3 2026
- JTC Employer Solutions Trustee Ltd 8.08M 股 · $389.17M · Q3 2026
- Mondrian Investment Partners LTD 4.97M 股 · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.92M 股 · $188.73M · Q3 2026
- EQUITY INVESTMENT CORP 3.56M 股 · $171.52M · Q3 2026
更多关于 SALT Holding Corp.
常见问题
How long has SALT Holding Corp. held GSK?
SALT Holding Corp. has disclosed GSK holdings in 4 of the last 8 reported quarters, going back to Q4 2024.
What is SALT Holding Corp.'s current position in GSK?
As of Q3 2026, SALT Holding Corp. holds 235.46K shares of GSK (GSK PLC), valued at $11.34M, representing 5.87% of its reported portfolio and ranking #5.
Has SALT Holding Corp. been buying or selling GSK?
In the latest 13F filing (Q3 2026), SALT Holding Corp. held unchanged its position in GSK. The position peaked in Q2 2026 at 235.46K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.